Mirzyme Therapeutics Limited

MirZyme Therapeutics is a UK biotechnology company developing an integrated precision medicine platform for preeclampsia, combining the UKCA-marked M-PREG® diagnostic with first-in-class oral therapeutics designed to predict, prevent and monitor one of the leading causes of maternal and perinatal mortality worldwide. MirZyme’s mission is simple: One Test. One Pill. Save Two Lives.